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Abstract
Extracts from pods and leaves of carob (Ceratonia siliqua L.) were tested for their ability
to inhibit cell proliferation of mouse hepatocellular carcinoma cell line (T1). The two extracts
showed a marked alteration of T1 cell proliferation in a dose-related fashion reaching the
maximal effect at 1 mgyml. Moreover, we demonstrated that leaf and pod extracts were able
to induce apoptosis in T1 cell lines after 24-h treatment mediating a direct activation of the
caspase 3 pathway. HPLC analysis revealed the presence of gallic acid, (y) epigallocatechin-
3-gallate and (y) epicatechin-3-gallate in pod and leaf extracts, compounds well known to
exert antiproliferative effects. Their concentration reached 6.28 mgyg in carob leaves and
1.36 mgyg in carob pods extract. The discovery that carob pod and leaf extracts contained
antiproliferative agents could be of practical importance in the development of functional
foods andyor chemopreventive drugs.
 2002 Elsevier Science B.V. All rights reserved.
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1. Introduction
Ceratonia siliqua L. is a typical plant of the Mediterranean area, which is mainly
used in the food industry as source of gum extracted from the seeds. Carob meal
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contains among total polyphenols a high level of proanthocyanidins in comparison
to hydrolysable ones represented by ellagitannins and gallotannins w1x.
Interest has focused on flavonoids potential benefits to human health, as they are
ubiquitously present in foods of plant origin and some epidemiological studies
evidenced that the consumption of foods rich in these compounds could reduce the
risk for certain types of cancer and heart diseases mortality w2–5x. In this context,
it has been shown that oral consumption of polyphenols offers protection against
all stages of carcinogenesis w5,6x. Several mechanisms of anticancer activity of
catechins have been postulated, such as an inhibition of urokinase w7x, inhibition of
angiogenesis w8x and inhibition of cell growth and proliferation processes w9x, but
none seem universal for all cancers.
Recent studies have demonstrated that also theaflavins, procyanidins and other
naturally occurring low molecular phenolic acids, such as gallic, chlorogenic and
caffeic acid, have strong antioxidant and cancer chemopreventive properties w10–
14x.
The aim of the present study was to investigate the ability of aqueous extract of
pod and leaf of carob to inhibit cell proliferation of mouse hepatocellular carcinoma
cell line (T1).
2. Experimental
2.1. Materials
Samples of pod and leaf of C. siliqua were collected during August–September
2001 in the eastern parts of Sicily (Italy) where they naturally grow and identified
by Prof. P. Zanoli, Prof. of Pharmacognosy, Department of Pharmaceutical Sciences,
college of Pharmacy, Modena and Reggio Emilia University (Modena, Italy).
Voucher specimen was deposited in the same University. Samples were stored at
room temperature and analysed within 2 months of collection. The plant material
(pod or leaf) was crushed in a mechanical mill and the resulting powder was
extracted as described below.
Standards of (q)-catechin (C), (y)-epicatechin (EC), (y)-epigallocatechin-3-
gallate (EGCG,), (y)-epicatechin-3-gallate (ECG), (y)-epigallocatechin (EGC),
gallic acid (GAc), theophilline (T), caffeine (Ca), chlorogenic acid (ClAc), caffeic
acid (CAc) and cathecol (Ct), were purchased from Sigma (Milan, Italy). HPLC-
grade methanol and acetonitrile and phosphoric acid of analytical grade were
purchased from Carlo Erba Reagenti (Milan, Italy). For the preparation of all
samples and solutions distilled water deionized with Milli-Q Water Purification
System (Millipore, Bedford, Massachusetts, USA) was used.
2.2. Extracts preparation
The extracts were prepared infusing 1 g of carob pods or leaves powder with 100
ml of boiling water for 15 min. The infusions were then centrifuged at 20 000=g
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for 10 min and the supernatants were collected and lyophilised. The lyophilised
samples were then used for the assay on cell proliferation and apoptosis.
For HPLC analysis the supernatant was collected, filtered through 0.45 and 0.22
mm Cellulose Acetate filter devices (Sigma) and then diluted properly in water.
2.3. Cells and treatments
The T1 cell line, originally cloned from the solid hepatocellular carcinoma from
transgenic mice showing an over expression of c-myc and TGF a genes, was a kind
gift of Dr Snorri Thorgeirsson (Chief, Laboratory of Experimental Carcinogenesis
Division of Basic Sciences, National Cancer Institute, NIH, Bethesda, MA).
The cell lines were cultured on polystyrene culture dishes (Dasit, Milano, Italy)
and grown in DMEM without L-glutamine plus HAM’s F 12 medium (1:1),
containing 1 mgyml galactose, 18 mM HEPES, 5 mM Na pyruvate, 30 mgyml
proline, 10% ITS 100=, 2 mM glutamine, 0.1% gentamicin (all purchased from
Sigma-Aldrich, Milano, Italy) referred as T1 medium (T1M) and supplemented
with 10% FBS. For the assay a solution of lyophilised samples in T1M medium
ranging from 1 to 0.1 mgyml was used. The number of cells was assessed by
optical microscope using a magnification 40= (Nikon, Japan).
2.4. BrdU cell proliferation assays
T1 cells were plated on 96-well plates at concentration of ;10 000 cellsywell in
T1M and supplemented with either 10 or 0.1% FBS. The cells were then incubated
with different concentrations from 1 to 0.1 mgyml of pod or leaf extracts for 24 h;
4 h prior to the end of incubation, 5-bromo-29-deoxyuridine (BrdU) was added to
each well (10 mM). Differences in cell proliferation were analysed by measuring
the amount of BrdU incorporation determined by a Multiskan MCC 340 system
(Labsystem Oy, Helsinki, Finland). Incorporation was measured at 450 nm (reference
at 690 nm).
2.5. Detection of apoptosis
2.5.1. TUNEL-modified assay
T1 cells line were seeded on cover sleeps in 35-mm dishes (Dasit) in the
appropriate culture medium. Apoptosis was assessed by the terminal-deoxynucleo-
tidyltransferase (TnT)-mediated dUTP-biotine Nick-End Labelling modified assay
(TUNEL), using a DeadEnd Colorimetric Apoptosis Detection System provided by
Promega (Milano, Italy).
Briefly, the cells treated with 0.2 mgyml of leaf extracts or 0.4 mgyml of pod
extracts for 24 h were rinsed in PBS and fixed in 4% paraformaldehyde solution,
washed with PBS and incubated with biotinylated nuclotides for 60 min at 37 8C,
washed with PBS and incubated for 5 min at room temperature in 0.3% hydrogen
peroxide (Sigma). Cells were then rinsed in PBS and detection of DNA fragmen-
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Table 1
Gradient elution system
Time % A % B % C % D
(min) H O2 0.5% Phosphoric Acetonitrile Methanol
acid
0 68 22 4 6
18 58 22 8 12
23 54 22 12 12
40 36 22 30 12
tation was carried out by incubating the cells with DAB solution for 10 min at
room temperature.
The staining was assessed by optical microscope using a magnification 40=
(Nikon, Japan).
2.5.2. Protease assay
Caspase-3-related protease activity in cell lysates was determined using a com-
mercially available kit (Promega). Briefly, T1 cells were treated with 0.2 mgyml of
leaf extracts or 0.4 mgyml of pod extracts alone or in association with the pan-
caspase inhibitor Z-VAD-FMK (50 mM) for 24 h. Cell lysate proteins (nuclei free),
were mixed with assay buffer (containing 10 mM DTT) and with the colorimetric
substrate DEVD-pNA (20 mmol) followed by incubation at 37 8C for 4 h.
Absorbance was then read at 405 nm using a Multiskan MCC 340 system.
2.6. HPLC analysis
The main stock solutions of all standards were prepared by dissolving weighted
quantities of the analytes in the initial mobile phase used for the chromatographic
separation H Oyphosphoric acid 0.5%yacetonitrileymethanol (68:22:4:6). Catechins,2
gallic acid, caffeine and theophilline were prepared at the concentration of 10 mgy
ml; chlorogenic acid at the concentration of 25 mgyml; caffeic acid at the
concentration of 30 mgyml; cathecol at the concentration of 80 mgyml and the tea
extract at the concentration of 75 mgyml. The standard mixtures for calibration
were prepared diluting these stock solutions in the same mobile phase with
concentrations ranging from 0.25 to 500 mgyml. Stock solutions and standards
mixtures were stored in darkness at y20 8C.
The HPLC system consisted of a LaChrom L-7100 quaternary pump, a L-7612
Vacuum Solvent Degasser for in-line degassing of the mobile phase, a rheodyne
manual injector with a 50 ml loop and a LaChrom L-7455 Diode Array Detector.
Data analysis was performed using a D-7000 computer interface and a D-7000
HPLC System Manager software (Merck-Hitachi, Darmstadt, Germany).
The chromatographic separation was performed on an analytical Microsorb-MV
RP-C 100 A column (250=4.6 mm), placed in a water bath set at 40 8C. The18 ˚
solvents used for gradient elution were (a) H O, (b) phosphoric acid 0.5%, (c)2
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acetonitrile and (d) methanol; the flow rate was set at 1 mlymin; and the gradient
elution profile is presented in Table 1. After every injection, the column was re-
equilibrated with initial conditions for 15 min. UV-Vis absorbance spectra (ls
198–708 nm) were collected continuously during the course of each chromatogram
and used for the peak purity determination. Peaks in the samples were identified by
comparing their retention times and UV-Vis spectra with those of the reference
standards, after subtraction of the corresponding base spectrum. Peak areas obtained
at 205 nm were used for the construction of calibration curves.
2.7. Statistical analysis
All experiments were repeated at least three times to ensure the reproducibility.
All assays and quantitative measurements were performed in quadruplicate. Com-
parison of multiple means was performed with one-way ANOVA with the Bonfer-
roni’s test and Dunnett’s post hoc test (Graph Pad Inc.) Ps for unpaired t-test and
one-way ANOVA are provided in the text.
3. Results
3.1. Modulation of T1 cell proliferation
Incubation of T1 cell line for 24 h with pod and leaf extracts of carob significantly
inhibited the proliferation of the carcinoma cell line. The two extracts showed a
marked reduction of T1 cell proliferation in a dose-related fashion reaching the
maximal effect at 1 mgyml (Fig. 1). In particular, the treatment with 0.2, 0.4 and
0.8 mgyml of extracts, produced a significant inhibition (P-0.001) of incorporation
of BrdU, whereas at 0.1 mgyml, both extracts did not show any significant change
compared to the non-treated cells.
Interestingly, the IC of leaf extracts was lower than that of pods extracts,50
ranging from 0.2 to 0.4 mgyml, respectively, suggesting the presence, in the leaf
extract, of a considerably higher amount of compounds able to inhibit cell
proliferation.
3.2. Induction of apoptosis
Pod and leaf extracts were able to induce apoptosis in T1 cell lines as indicated
by the darker staining of nuclei of treated cells. The DNA fragmentation was evident
after 24-h treatment (Fig. 2b,c). The exposure to the vehicle did not cause nuclear
alterations as confirmed by the absence of any staining (Fig. 2a). The effect on
apoptosis elicited by leaf extracts used at 0.2 mgyml was greater than that obtained
with pod extracts used at 0.4 mgyml.
Cell lysates treated with pod and leaf extracts exhibited a significant increase in
peptide cleavage activity compared to the non-treated cells (P-0.05). The observed
cleavage of DEVD was mostly due to the activation of the caspase pathway, since
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Fig. 1. Effect of aqueous extract of pods and leaves of carob on cell proliferation of mouse hepatocellular
carcinoma cell line (T1). Inhibition of T1 cells proliferation elicited by pod extract (straight line) and
leaf extract (dots line) are expressed as % of control "S.E. One way ANOVA (Dunnett test) indicates
that T1 cell proliferation was significantly inhibited by treatment with leaf and pod extracts at all the
concentrations tested (P-0.001).
pre-treating the T1 cells with the pan-caspase inhibitor Z-VAD-FMK induced a
complete block of the DEVD cleavage (Fig. 3).
3.3. Analysis of polyphenols
The chromatogram of an injection of a standard mixture at optimum conditions
is shown in Fig. 4 and the characteristics of the standard mixtures are reported in
Table 2. All compounds exhibited good linearity over the range tested, with
correlation coefficients of 0.992–0.999. The UV-Vis spectra obtained for each
standard peak, after subtraction of the UV-Vis base spectrum, were computer
normalised, superimposed and utilised for sample identification.
The quantitative results are reported in Table 3. Every peak was analysed using
DAD and the HSM software: peak purity check confirmed that there were no co-
eluting compounds affecting the separation, meanwhile identification was carried
out comparing retention times and UV-Vis spectra (r always )0.97) with that of2
standards. GAc, EGCG and ECG were found both in pod and leaf extracts while C
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Fig. 2. Effect of aqueous extract of pods and leaves of carob on apoptosis in mouse mouse hepatocellular
carcinoma cell line (T1). Treatments with leaf extracts w0.2 mgyml, (b)x or pod extracts w0.4 mgyml,
(c)x causes DNA fragmentation in many cells as shown by the dark brown nuclear staining (arrows),
indicating an increase of apoptotic processes. On the contrary, non-treated cells (a) showed no dark
staining. Magnification 40=.
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Fig. 3. Effect of aqueous extract of pods and leaves of carob on caspase-3 activity in mouse hepatocellular
carcinoma cell line (T1). One way ANOVA (Bonferroni) indicates that induction of caspase-3 activity
was significantly inhibited by treatment with leaf and pod extracts at 24 h (*sP-0.05).
Fig. 4. Chromatogram at ls205 nm of a standard mixture (25 mgyml ClAc; 15 mgyml CAc; 5 mgyml
all other analytes).
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Table 2
Standards characteristics, linearity and day-to-day variation
RT"S.D.a Concentration range Linear regression ysb
aXqb
Correlation Coefficient of vari-
ation (%)c(mgyml)
a b
coefficient
Intra-day Inter-day
G Ac 4.2"0.03 0.3–80 168783.6 299258.36 0.994 3.89 4.01
Ct 8.4"0.11 1–350 81635.2 1576306 0.994 3.63 3.79
T 9.4"0.06 0.3–80 229789.8 394896.7 0.993 3.80 4.03
EGC 10.3"0.07 0.3–80 248701.5 666964.0 0.994 4.23 4.42
C 10.8"0.07 0.3–80 285714.7 1313438 0.992 3.68 3.68
Cl Ac 12.8"0.1 0.8–250 51577.30 21809.91 0.999 3.65 4.19
C Ac 13.9"0.11 0.7–200 93713.66 58917.54 0.999 3.30 4.19
Ca 15.4"0.11 0.3–80 229155.4 131290.0 0.999 4.95 5.19
EGCG 16.1"0.14 0.3–80 320218.6 1358269 0.998 3.10 4.42
EC 16.9"0.15 0.3–80 308116.2 904935.5 0.994 3.67 3.93
ECG 24.4"0.13 0.3–80 313256.1 725123.9 0.997 4.39 4.62
Values are average of 18 determinations " standard deviation (S.D.).a
Results derived from linear regression analysis of standard peak areas (UVys) at 205 nm vs. knownb
concentrations (mgyml); yspeak area, xsconcentration; all determinations are the mean of at least three
replicates for six different concentrations.
Values are results of three runs a day for 3 consecutive days.c
Table 3
Total amount of polyphenol present in carob leaves and pods extracts
Carob leaves mgyg"S.D.* Carob pod mgyg"S.D.*
I infusion II infusion Total I infusion II infusion Total
G Ac 3.34"0.03 0.96"0.02 4.30 0.87"0.00 0.33"0.00 1.20
Ct – – – – – –
T – – – – – –
EGC – – – 0.05"0.00 0.01"0.00 0.06
C – – – 0.01"0.00 – 0.01
Cl Ac – – – – – –
Ca Ac – – – – – –
Ca – – – – – –
EGCG 1.23"0.41 0.28"0.03 1.51 0.01"0.00 – 0.01
EC – – – – – –
ECG 0.47"0.09 – 0.47 0.06"0.00 0.02"0.00 0.08
Total 5.04 1.24 6.28 1.00 0.36 1.36
sMean and S.D. of three determinations.*
was present, although only in small amounts, in carob pod extracts. EC, one of the
major polyphenols found in green and black tea, was absent in both extracts. The
polyphenols detected in our experimental conditions reached 6.28 mgyg in carob
leaves and 1.36 mgyg in carob pod extracts.
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4. Discussion
In these last years relevant attention has been focused on the capability of dietary
constituents such as the epicatechins, the polyphenolic compounds present in large
amounts, i.e. in green tea, to act as chemopreventives and anticarcinogens w15x. The
idea to use fruits and leaves of carob, a typical Mediterranean plant, as a source of
polyphenols, was raised after the evidence that carob pods contained a high amount
of antioxidant compounds such as gallotannins w1x. Up to now, carob pods are
mainly devoted to animal feeding because of their excessive astringency due to the
high presence of the tannins. We started, then, to characterise qualitatively and
quantitatively the polyphenols present in carob pods in order to figure out the
possibility to extract such compounds and to use it as nutraceutical preparation, and
in addition, to obtain a high quality pod meal with less astringency property. In this
ongoing project we found that substances present in the pods aqueous extracts,
exerted a good anti-proliferative effect on T1 cell line.
This result prompted us to study if the extracts of other parts of the plant were
able to induce the same effect. In particular we used the carob leaves, thought to
be a better source of these compounds and in particular of polyphenols. Our results
indeed showed that carob leaves extract produced an inhibition of T1 cell prolifer-
ation significantly higher than that produced by carob pods extract at all the
concentrations tested. This effect seems to be related to the induction of apoptosis,
since the leaf and pod extracts showed, even if with different potency, a significant
increase of caspase-3 activity compared to that found in the control cells. Given the
extraordinary ability of green tea leaf extracts, which are rich in catechins, to inhibit
cell proliferation, we could surmise that the effects elicited by the two extracts,
could be primarily related to the presence of gallotannins and gallic acid. As pointed
out in the results, we found a higher amount of different flavonoids, such as EGCG
and ECG and also of the GAc in the leaf extracts compared to the pod extracts.
However, since we tested the activity of total extracts, we cannot exclude that other
compounds could contribute to the inhibition of tumoral cell proliferation.
Although further studies are necessary to evaluate the molecular basis which
underwent the effect of these compounds, our findings could represent an improve-
ment in the biological and pharmacological characterisation of the compounds
present in C. siliqua.
Moreover, given the extraordinary ability of leaf and pod extracts to inhibit
tumour cell proliferation our finding could be useful for the future strategies against
the cell mitogenic activity and, therefore, cancer progression.
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